Author Correction: THBru attenuates diabetic cardiomyopathy by inhibiting RAGE-dependent inflammation.
Xu HH, Hao SX, Sun HY, Dong XX, Lin Y, Lou H, Zhao LM, Tang PP, Dou ZJ, Han JJ, Du MH, Chen ZX, Kopylov P, Shchekochikhin D, Liu X, Zhang Y.
Xu HH, et al. Among authors: dong xx.
Acta Pharmacol Sin. 2025 Jan 30. doi: 10.1038/s41401-025-01483-0. Online ahead of print.
Acta Pharmacol Sin. 2025.
PMID: 39885313
No abstract available.